The Enterprise Value as of September 2024 (TTM) for Horizon Therapeutics Public Limited Company (HZNP) is 92.83M

According to Horizon Therapeutics Public Limited Company’s latest financial reports and current stock price. The company's current Enterprise Value is 92.83M. This represents a change of -99.59% compared to the average of 22.38B of the last 4 quarters.

Horizon Therapeutics Public Limited Company (HZNP) Historical Enterprise Value (quarterly & annually)

How has HZNP Enterprise Value performed in the past?

The mean historical Enterprise Value of Horizon Therapeutics Public Limited Company over the last ten years is 9.08B. The current 92.83M Enterprise Value has changed 2.24% with respect to the historical average. Over the past ten years (40 quarters), HZNP's Enterprise Value was at its highest in in the September 2021 quarter at 26.27B. The Enterprise Value was at its lowest in in the September 2013 quarter at 203.50M.

Horizon Therapeutics Public Limited Company (HZNP) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Horizon Therapeutics Public Limited Company Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Horizon Therapeutics Public Limited Company (HZNP) Average Enterprise Value

How has HZNP Enterprise Value performed in the past?

The current Enterprise Value of Horizon Therapeutics Public Limited Company (HZNP) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Horizon Therapeutics Public Limited Company (HZNP) Enterprise Value vs. Peers

How is HZNP’s Enterprise Value compared to its peers?

Horizon Therapeutics Public Limited Company’s Enterprise Value is less than Bristol-Myers Squibb Company (146.44B), less than AbbVie Inc. (399.11B), less than Merck & Co., Inc. (325.14B), less than Gilead Sciences, Inc. (118.58B), less than Johnson & Johnson (412.32B), less than Amgen Inc. (225.59B), less than Eli Lilly and Company (883.63B), less than AstraZeneca PLC (284.12B), less than Sanofi (147.45B), less than Novartis AG (249.31B), less than GSK plc (81.81B), less than Roche Holding AG (251.71B),

Build a custom stock screener for Horizon Therapeutics Public Limited Company (HZNP) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Horizon Therapeutics Public Limited Company using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Horizon Therapeutics Public Limited Company (HZNP) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Horizon Therapeutics Public Limited Company or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.